Impax Laboratories (IPXL) Purchases Two Generic Products from Actavis (ACT) in All-Cash Deal
Tweet Send to a Friend
Impax Laboratories, Inc. (Nasdaq: IPXL) announced that it has acquired from Actavis plc (NYSE: ACT) two generic products for cash ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
